Klingensmith Harvey Robert (CIK 1800107) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-07). Recent activity: Buy CLB (8,069 shares), Buy CLB (9,317 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | Core Laboratories Inc. /DE/ (CLB) | Director | Buy | 8,069 | $0 |
| 2025-04-02 | Core Laboratories Inc. /DE/ (CLB) | Director | Buy | 9,317 | $0 |
Source: SEC Form 4 filings · as of 2026-04-07